Kin-Ming Lo

This inventor holds 40 USPTO granted patents and 8 published patent applications, plus 8 CIPO patents and 12 EPO patents, primarily in Cancer Immunotherapy. Top assignees: Merck Patent Gmbh, Emd Lexigen Research Center Corp., Emd Serono Research Center, Inc.. Active years: 1996-2022.

USPTO Granted Patents = 40 (Patent Applications = 8)

% Patents Active = 47.5

CIPO Patents = 8 (Patent Applications = 3)

EPO Patents = 12 (Patent Applications = 9)

Average Co-Inventor Count = 2.7

ph-index = 19

Forward Citations = 1,402(Granted Patents)

Location History:

Wellsley, MA (US) (1996)
Wellesley, MA (US) (1996 - 1998)
Lexington, MA (US) (2003 - 2022)

Company Filing History:

Emd Lexigen Research Center Corp.

patents

3 out of 3

Emd Serono Research Center, Inc.

patents

4. 3 out of 6

Fuji Immunopharmaceuticals Corp.

Antisoma Research Limited

patents

where one patent can have more than one assignee

Years Active: 1996-2022

Loading Chart...

Areas of Expertise:

TGF-β Inhibition

Antibody Fusion Proteins

Interleukin-12 Variants

Cytokine Therapy

Angiogenesis Inhibitors

Fc Fusion Proteins

Targeted Immune Therapy

Tumor Specific Antibodies

Hybrid Antibodies

Immunocytokines

Nucleic Acids

Protein Expression Technology

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11370819 - Targeted TGFβ inhibition (2022-06-28),

2. 11021694 - SIRP-α immunoglobulin fusion proteins (2021-06-01),

3. 9676863 - Targeted TGFβ inhibitors (2017-06-13),

4. 9029330 - Methods of treating cancer using interleukin-12p40 variants having improved stability (2015-05-12),

5. 8907066 - Antibody fusion proteins with a modified FcRn binding site (2014-12-09),

6. 8703908 - Expression and export of angiogenesis inhibitors as immunofusins (2014-04-22),

7. 8562986 - Engineered anti-alpha V-integrin hybrid antibodies (2013-10-22),

8. 8557232 - Stabilization of Fc-interferon-beta fusion proteins (2013-10-15),

9. 8470991 - Immunocytokine sequences and uses thereof (2013-06-25),

10. 8420087 - Interleukin-12 targeted to oncofoetal fibronectin (2013-04-16),

11. 8206718 - Expression and export of angiogenesis inhibitors as immunofusins (2012-06-26),

12. 8188248 - Nucleic acids encoding interleukin-12P40 variants with improved stability (2012-05-29),

13. 8066994 - Proteins comprising an IgG2 domain (2011-11-29),

14. 8043608 - Methods of using Fc-cytokine fusion proteins (2011-10-25),

15. 7955590 - Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens (2011-06-07),

Title: Inventor Kin-Ming Lo: Pioneering Innovations in Lexington

Introduction: Kin-Ming Lo is a distinguished inventor based in Lexington, MA, known for his groundbreaking contributions to various technological fields.

Latest Patents: Kin-Ming Lo holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his versatility and ingenuity in innovation.

Career Highlights: With a career spanning over two decades, Kin-Ming Lo has worked with leading research institutions and companies, consistently pushing the boundaries of technology and creating solutions to complex problems.

Collaborations: Throughout his career, Kin-Ming Lo has collaborated with top engineers, scientists, and researchers, fostering a culture of innovation and knowledge-sharing to drive progress in the industry.

Conclusion: Kin-Ming Lo's passion for innovation and his dedication to creating impactful solutions have solidified his reputation as a visionary inventor in Lexington and beyond.